News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Origen Therapeutics, Inc. Appoints Phil Leighton as Director of Research and Announces Departure of Robert Etches, VP of Research


6/23/2008 8:50:37 AM

EMERYVILLE, Calif.--(BUSINESS WIRE)--Origen Therapeutics today announced a change in the research management of the company appointing Dr. Phil Leighton as Director of Research, following the departure of Robert Etches, Ph.D., D. Sc., Vice President of Research. This change marks the company’s transition from development of its proprietary avian transgenic technology to the application of that technology to product development in the pharmaceutical, food and agricultural arenas.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES